Home/Pipeline/MiQuant® dPCR Assays (AAV, CAR-T, Residual DNA)

MiQuant® dPCR Assays (AAV, CAR-T, Residual DNA)

Quantitative analytics for cell and gene therapy

Commercial LaunchActive

Key Facts

Indication
Quantitative analytics for cell and gene therapy
Phase
Commercial Launch
Status
Active
Company

About Minerva Biolabs

Minerva Biolabs is a specialized provider of contamination control products and services, serving the global life sciences market from its base in Cologne, Germany. The company's core expertise lies in the detection and elimination of mycoplasma and other contaminants in cell cultures, complemented by a growing portfolio for nucleic acid extraction, PCR consumables, and lab cleaning. It operates a hybrid business model, selling proprietary kits and reagents while also offering contract manufacturing services. With a focus on compliance with international pharmacopeial standards (EP, USP, JP), Minerva targets academic, pharmaceutical, and biotech customers who require high-quality, reliable contamination management.

View full company profile